Na Wu Tingyao

Inā ʻaʻole no ka hoʻomanaʻo ʻana i ka World Hepatitis Day, hiki iā mākou ke hoʻolohe wale i ke kiaʻi ʻana i ka novel coronavirus a poina iā mākou aia nā maʻi hepatitis e hūnā ana i ka pōʻeleʻele.

No ka mea ʻaʻole paʻakikī ka maʻi hepatitis iā mākou e hanu a koi iā mākou e hoʻopaʻa ʻia e like me ka coronavirus novel, hoʻowahāwahā pinepine mākou iā ia, akā ʻaʻole kēia manaʻo e poina iā mākou.I nā makahiki lōʻihi, e hoʻohana ka maʻi maʻi hepatitis i ka palekana haʻahaʻa e hoʻokuke iā mākou mai ka maʻi hepaʻa i kēlā me kēia pae i ka hohonu o ka cirrhosis ate, ka hāʻule ʻole o ka ate a i ʻole ka maʻi maʻi ate.

Ke kumu o ka World Hepatitis Day

Ke hoʻonohonoho ʻia kahi maʻi e ka World Health Organization ma ke ʻano he "World Day" e hāpai i ke koʻikoʻi o ka pale ʻana a me ka mālama ʻana i nā kānaka a pau, ʻo ia ka mea pinepine ʻaʻole maopopo i ka poʻe maʻamau ka paʻakikī o ka maʻi.

I mea e hoʻonui ai i ka manaʻo o ka poʻe i ka pale ʻana a me ka mālama ʻana i ka maʻi hepatitis (ʻoi aku ka maʻi hepa B a me C), ua koho nā mokuʻāina āpau o ka WTO i Iulai 28 ʻo ka World Hepatitis Day ma ka 63rd World Health Assembly i mālama ʻia ma 2010.

Ua koho ʻia kēia lā no ka mea ʻo ia ka lā hānau o Baruch S. Blumberg (1925-2011), ka mea i ʻike i ka maʻi hepatitis B.

Ua ʻike ka ʻepekema ʻAmelika ʻAmelika i ka maʻi hepatitis B i ka makahiki 1963, a ma hope ua hōʻoia ʻo ia he hiki i ka maʻi hepatitis B ke hoʻoulu i ka maʻi kanesa, a ua hoʻomohala hou i nā ʻano ʻike a me nā lāʻau lapaʻau.Ua loaʻa iā ia ka Nobel Prizes in Physiology or Medicine i ka makahiki 1976 ma muli o ka ʻike ʻana i ke kumu a me ka hoʻoili ʻana o ka maʻi hepatitis B.

ʻAʻole pili maoli ka hepatitis iā ʻoe?

Ke hopohopo nei paha ka World Health Organization i ka nānā wale ʻana o nā mea a pau i ka COVID-19.Ma waho aʻe o ka hoʻonohonoho ʻana i ke poʻomanaʻo o ka World Hepatitis Day o kēia makahiki ʻo "ʻAʻole hiki ke kali ʻo Hepatitis", ua hoʻoikaika pū ʻia ma kāna pūnaewele kūhelu:

Make hoʻokahi kanaka mai nā maʻi hepatitis i kēlā me kēia 30 kekona, ʻoiai i ka pilikia COVID-19 i kēia manawa.ʻAʻole hiki iā mākou ke kali.Pono mākou e hana koke i ka maʻi hepatitis viral.

Mai manaʻo ʻaʻole ʻoe pili i ka maʻi hepatitis.Ma ka hihia o ka ma'i hepa B, ka mea i ho'opilikia i ka heluna nui loa o na kanaka, e like me ka WHO koho, he 10% wale no ka poe i ma'i i ike ua loaa lakou i ka ma'i, a he 22% wale no ka poe i loaa i ka ma'i.

ʻOi aku ka kiʻekiʻe o ka nui o ka poʻe i loaʻa i ka maʻi hepatitis C me ka ʻike ʻole a mālama ʻole ʻia no ka mea e like me ka hapa nui o ka poʻe i loaʻa i ka maʻi hepatitis B, hiki i ka maʻi hepatitis C ke hoʻomau i nā makahiki me ka ʻole o nā hōʻailona.Ke ʻike ʻia, ʻeha pinepine ka ate a paʻakikī ke mālama.

ʻOiai aia i kēia manawa nā lāʻau lapaʻau hepa B e hiki ke pale i ka loaʻa ʻana o ka maʻi maʻi hepatitis maʻi, cirrhosis a me ka maʻi ʻaʻai ake, ʻaʻohe kano hepa C i loaʻa.ʻOiai hiki i nā lāʻau antiviral ke ho'ōla ma mua o 95% o nā maʻi maʻi hepa C, ma laila e pale ai i ka hiki ʻana mai o ka cirrhosis a me ka maʻi ʻaʻai ate, ʻaʻole hiki i ka poʻe maʻi ke loaʻa i ka maʻi a me ka mālama ʻana no laila ʻaʻohe manawa e hoʻohana ai i nā lāʻau antiviral.

ʻOiai ʻo nā antibodies i hoʻokomo ʻia e ka maʻi hepa B hiki ke hoʻoikaika i ka 98% -100% ka pale ʻana i ka maʻi ate a me ka maʻi ʻaʻai ate, aia nō kekahi helu liʻiliʻi o ka poʻe i loaʻa ʻole nā ​​antibodies ma hope o ka hoʻopaʻa ʻia ʻana a ʻo ka poʻe i laki e hana i nā antibodies. ʻike pinepine i ka nalowale o nā antibodies me ka makahiki.

Wahi a kekahi noiʻi ʻana o nā haumāna ma Taipei i alakaʻi ʻia e National Taiwan University Hospital, 40 pakeneka o ka poʻe i loaʻa i nā ʻano ʻekolu o ke kano i ka wā kamaliʻi ʻaʻole i ʻike ʻia nā antibodies hepatitis B ma mua o ka makahiki 15, a hiki i ka 70 pakeneka o lākou ʻaʻole i loaʻa i ka maʻi hepa. ʻO nā antibodies B ma ka makahiki 20.

ʻAʻole i ʻike ʻia nā antibodies i ke kino, ʻaʻole ia he mana pale.ʻO ia wale nō paha ka emi ʻana o ka mana pale o ke kino, akā ua hoʻomanaʻo mai kēia ʻoiaʻiʻo iā mākou ʻaʻole hiki ke hoʻopaʻa i ka maʻi hepa B no ke ola wale nō ma o ke kano, ʻaʻole hoʻi e ʻōlelo ʻia ʻaʻohe lāʻau lapaʻau no ka hepatitis C.

Ua hōʻoia ʻia nā haʻawina haukaʻi he maikaʻi ʻo Ganoderma lucidum i ka mālama ʻana i ka maʻi hepatitis.

Ua haʻi ʻo Polofesa Zhibin Lin mai ke Kulanui o Peking i nā hopena o Ganoderma lucidum i ka maʻi hepatitis ma nā ʻatikala, nā puke a me nā haʻiʻōlelo:

Mai ka makahiki 1970, ua hōʻike ʻia ka nui o nā hōʻike lapaʻau i ka nui o ka nui o ka nui o ka hoʻomākaukau ʻana o Ganoderma i ka mālama ʻana i ka maʻi hepaʻa he 73% a 97%, a ʻo ka maʻi lapaʻau lapaʻau he 44 a 76.5%.

ʻO Ganoderma lucidum wale nō ka hopena maikaʻi i ka mālama ʻana i ka maʻi hepatitis acute;ʻO Ganoderma lucidum ka hopena o ka hoʻonui ʻana i ka maikaʻi o nā lāʻau antiviral i ka mālama ʻana i ka maʻi hepatitis maʻi.

I loko o 10 mau hōʻike noiʻi i paʻi ʻia e pili ana i ka maʻi hepatitis viral, ʻoi aku ma mua o 500 mau hihia o Ganoderma lucidum i hoʻohana wale ʻia a i hui pū ʻia me nā lāʻau anti-hepatitis virus i ka mālama ʻana i ka maʻi hepatitis viral i hōʻike ʻia.ʻO nā hopena curative penei:

(1) Ua emi a nalowale nā ​​hōʻailona kumuhana e like me ka luhi, ka pau ʻana o ka ʻai, ka ʻeha o ka ʻōpū, a me ka ʻeha o ke ake;

(2) Ua hoʻihoʻi ka Serum ALT i ka maʻamau a i ʻole ka emi ʻana;

(3) Ua hoʻi hou ka ate a me ka spleen i ka mea maʻamau a i ʻole ka emi ʻana i nā pae like ʻole.

Hoʻomaikaʻi ʻo Ganoderma lucidum i ka maʻi hepatitis mau loa.

Ua ʻōlelo ʻo Zhibin Lin i nā manawa he nui i kāna mau haʻiʻōlelo a me kāna mau kākau ʻana e hiki ke hoʻohana wale ʻia ʻo Ganoderma a i hui pū ʻia me nā lāʻau lapaʻau komohana no ka mālama ʻana i ka maʻi hepatitis mau loa.

Ua hōʻoia ʻia kahi hōʻike lapaʻau mai ka Halemai Kanaka o Jiangyin City, Jiangsu Province ʻo ka hoʻokele waha o 6 Ganoderma lucidum capsules (me 9 grams o Ganoderma lucidum maoli) i kēlā me kēia lā no 1 a 2 mau mahina i ʻoi aku ka maikaʻi ma mua o ka Xiao Chaihu Tang granules (kahi maʻamau. hoʻohana i ka lāʻau lapaʻau Kuʻuna Kina) i ka mālama ʻana i ka maʻi hepa B. ʻAʻohe o nā hōʻailona kumuhana, nā kuhikuhi pili, a i ʻole ka helu o nā maʻi i loko o ke kino, ua hoʻomaikaʻi nui ka hui Ganoderma.

ʻO ka noiʻi lapaʻau i mālama ʻia e ka Second Clinical Medical College of Guangzhou University of Chinese Medicine i hōʻoia i ka hoʻokahi makahiki o ka mālama ʻana me Ganoderma lucidum capsules (1.62 grams o Ganoderma lucidum crude drug i kēlā me kēia lā) a me Lamivudine (he lāʻau antiviral) i hoʻomaikaʻi i ka. ʻO ka hana ate o nā maʻi hepa B a hoʻopuka i kahi hopena antiviral maikaʻi.

Eia kekahi, ua paʻi ʻia kahi hōʻike lapaʻau ma New Medicine e Gao Hongrui et.al.i ka lua o ka Halemai o Jilin City ma 1985 kuhikuhi mai ma hope o ka hoʻohana 'ana o Ganoderma lucidum papa (kēlā me kēia papa ua like ia me 1 gram o crude lāʻau lapaʻau) 3 manawa i ka lā i loko o ka lapaau ana o 30 hihia o na maʻi me HBsAg maikaʻi maʻi maʻi hepatitis ( makahiki 6 a 68 makahiki, me ka papa o oi aku mamua o 1 a 10 makahiki) no 2 a 3 mahina,

He 16 mau hihia i ʻike maikaʻi ʻia (HbsAg hoʻololi maikaʻi ʻole, hoʻihoʻi ʻia ka hana o ka ate i ka maʻamau, nalowale a hoʻomaikaʻi nui ʻia nā hōʻailona, ​​hoʻihoʻi ʻia ka ate a me ka spleen), 9 mau hihia (hoʻemi ʻia ka titer HBsAg i 3 mau manawa, hoʻomaikaʻi ka hana o ke ake, hoʻomaikaʻi ʻia nā hōʻailona), a wale nō. ʻAʻole kūpono nā hihia 3.He 90% ka nui o ka huina, a ua hōʻike hou ʻo Ganoderma lucidum i ka hopena maikaʻi o ka maʻi hepatitis.

Hoʻomaikaʻi ʻo Ganoderma lucidum i ka maʻi hepatitis.

ʻO ka hōʻike hoʻomaʻamaʻa lapaʻau i paʻi ʻia e Zhou Liangmei ma Shanxi Medical Journal i ka makahiki 1977 i hoʻopaʻa ʻia i ka hōʻuluʻulu o 32 mau hihia o ka maʻi hepatitis acute i mālama ʻia me ka pauka spore ma Pingwang District o Wujiang County - "Ua ʻoluʻolu ka hopena curative mai ka nalowale ʻana o ka jaundice i ka awelika o 6 a 7 nā lā a me ka nalo ʻana o nā hōʻailona e like me ka paʻa ʻana o ka umauma, ka maʻi maʻi, ka luaʻi ʻana, ka ʻai maikaʻi ʻole a me ka mimi melemele a me ka hoʻihoʻi ʻana o nā hana ate i loko o 15-20 mau lā.

Eia kekahi, ua nīnauele ka mea kākau i nā ʻike kūleʻa he nui o ka hoʻohana ʻana iā Ganoderma lucidum extract e hoʻomaikaʻi ai i ka maʻi hepatitis maʻi, ka maʻi hepatitis a me ka maʻi ʻaʻai.Ma waena o lākou, mahalo nui au iā Ms. Zhu i nīnauele ʻia i ka makahiki 2009.

Ua ulu ʻo ia i nā hua ma Taichung, Taiwan no nā makahiki he nui.Ma mua o kona kokoke ʻana i ke 60, ua ʻike ʻia ʻo ia he maʻi hepa B a me C me kāna mau papa kuhikuhi ate ALT a me AST ma mua o 200. ʻOiai ua lawe koke ʻo ia i ka lāʻau lapaʻau, ua piʻi mau nā helu ate ʻelua ma kahi o 1,000 i loko o ʻelua mahina mai ka palekana. nā lāʻau lapaʻau i nā lāʻau lapaʻau kālā ponoʻī.

Ma hope mai, ua hoʻomaka ʻo ia e ʻae i ka mālama ʻana me ka hoʻomākaukau ʻana o Ganoderma lucidum (wai wai + waiʻona) a me ka lāʻau lapaʻau komohana.Ma ke ʻano o kēlā me kēia lā o 27 grams o Ganoderma lucidum, ua hoʻi hou kāna mau papa kuhikuhi i ka maʻamau ma lalo o ʻelua pule.

Nā loina o ka hoʻohana ʻana iā Ganoderma lucidum e pale a mālama i ka maʻi hepatitis viral

ʻO nā haʻawina lāʻau lapaʻau i nā makahiki he 40 i hala iho nei ua hōʻoia e hiki iā Ganoderma lucidum ke pale i ke ake ma nā ʻano penei:

(1) Hoʻomaikaʻi i ka palekana: Hiki i ka Ganoderma lucidum polysaccharides ke kāohi i ka hana a me ka hoʻonui ʻana o ka maʻi hepatitis ma o ka hoʻoponopono pale ʻana i hiki i nā mea maʻi ke hoʻōla koke mai ka maʻi ʻoiai inā e noho pū lākou me ka maʻi.

(2) Ka pale ʻana i nā pūnaewele ate: ʻaneʻane pili nā maʻi hepa a pau i "ka heluna nui o nā radical manuahi e hoʻouka ana i nā pūnaʻi ate".Hiki i nā Ganoderma triterpenes a me nā polysaccharides ke hoʻonui i ka mana antioxidant o nā puʻupaʻa o ka ate, e hoʻopau pono i nā radical manuahi a hōʻemi i nā pōʻino i hoʻokumu ʻia e ka mumū e pale i nā pūnaeka ate.

(3) Hoʻoikaika i ka hana houʻana o nā pūnaewele ate: Ganoderma lucidum polysaccharides hiki ke hoʻoikaika i ka synthesis o ka protein i loko o ke akepaʻa a hoʻonui i ka hana hou o nā pūnaewele ate.

(4) Ka pale ʻana a me ka mālama ʻana i ka fibrosis ate: ʻO ka ate cirrhosis kekahi o nā kumu nui o ka make i nā poʻe maʻi me ka maʻi hepatitis viral, a ʻo ka fibrosis ate ke kumu mua o ka cirrhosis ate.Hiki i nā Ganoderma lucidum triterpenes a me nā polysaccharides ke hoʻoheheʻe i ka fiber i hana ʻia a keʻakeʻa i ka hoʻokumu ʻana o ka fiber ate.No laila, ʻo ka ʻai ʻana i ka Ganoderma lucidum i ka wā mua hiki ke kōkua i ka pale ʻana i ka hiki ʻana mai o ka cirrhosis ate.

(5) Ka pale ʻana a me ka mālama ʻana i ka maʻi maʻi ate: ʻO ka maʻi maʻi ate kekahi kumu nui o ka make i nā poʻe maʻi me ka maʻi hepa.Hiki i nā Ganoderma lucidum triterpenes ke kāohi i ka hoʻonui a me ka metastasis o nā pūnaewele maʻi maʻi ate, a hiki i ka Ganoderma lucidum polysaccharides ke hoʻonui i ka hiki ke anti-cancer o ka ʻōnaehana pale.I ka manawa like, hiki i kēia mau mea nui ʻelua o Ganoderma lucidum ke hoʻonui i ka hiki ke detoxification o ke ake, a laila e hoʻoikaika ai i ka hopena pale a me ka therapeutic i ka maʻi maʻi ate.

(6) Hoʻemi i ka momona: Hiki i ka Ganoderma lucidum triterpenes a me nā polysaccharides ke hoʻemi i ka momona o ka ate (triglyceride), hoʻemi i ka mumū o ka ate, a hoʻemi i ka pōʻino o ke ake i hana ʻia e ka meaʻai kūpono ʻole.

(7) Ka pale ʻana i ka maʻi maʻi hepatitis: Wahi a kahi noiʻi i paʻi ʻia ma "Biotechnology Letters" i ka makahiki 2006 e ke Kula ʻo Life Science, South China Normal University, Guangzhou, ka mea nui triterpene o Ganoderma lucidum ─ ganoderic acids hiki ke pale pono i ka replication o ʻO ka maʻi hepatitis B i loko o nā pūnaʻi ate a pale i ka hoʻonui ʻana o ka maʻi me ka ʻole o ka hoʻopōʻino ʻana i nā pūnaʻi ate (e like me ka hōʻike ʻana ma ke kiʻi ma lalo).

No ka mea ʻaʻole e nalowale ka maʻi maʻi, e ʻoluʻolu e hoʻomau i ka ʻai ʻana iā Ganoderma lucidum.

Ma kahi o ka coronavirus novel a me ka maʻi hepatitis, pono mākou e aʻo pehea e noho maluhia ai me nā maʻi ʻē aʻe he nui.

ʻOiai ʻoi aku ma mua o hoʻokahi ʻenemi, loaʻa iā lākou ke kumu like o ka hana no ka ʻōnaehana pale.No laila, ʻo Ganoderma lucidum, hiki ke hakakā me ka maʻi hepatitis, he mea kaua maoli nō ia e kūʻē i ka coronavirus novel.

ʻOiai ua paʻa ka WHO e hoʻopau i ka maʻi hepatitis, pono mākou e ʻae ʻaʻole e nalowale ka maʻi hepatitis a i ʻole ka coronavirus hou mai ka ʻike e pili ana i ka maʻi maʻi no ka manawa lōʻihi.

Ma waho aʻe o ka hoʻokō ʻana i nā lula anti-epidemic, nā alakaʻi olakino a me nā lāʻau lapaʻau, ʻo ka mea hiki iā mākou ke hana ʻo ka ʻai ʻana i ka Ganoderma lucidum e mālama i ka pale ʻana i kahi kiʻekiʻe.A laila, ʻaʻohe ʻano o ka maʻi maʻi e hiki mai ana, maʻalahi ka maʻi koʻikoʻi, asymptomatic ka maʻi maʻalahi, a loaʻa iā mākou ke kino olakino ma hope.

HOPE

No ka mea kākau/ Ms. Wu Tingyao

Ua hōʻike ʻo Wu Tingyao ma ka lima muaʻO Ganoderma lucidumʻike

mai ka makahiki 1999. ʻO ia ke kumu oHoola me Ganoderma(i paʻi ʻia ma The People's Medical Publishing House ma ʻApelila 2017).

★ Ua paʻi ʻia kēia ʻatikala ma lalo o ka mana kūʻokoʻa o ka mea kākau, a no GANOHERB ka mea nona

★ ʻAʻole hiki ke hana hou ʻia nā hana i luna, ʻokiʻoki a hoʻohana ʻia ma nā ʻano ʻē aʻe me ka ʻole o ka ʻae ʻia e GanoHerb

★ Inā ua ʻae ʻia nā hana e hoʻohana ʻia, pono e hoʻohana ʻia i loko o ke ʻano o ka mana a hōʻike i ke kumu: GanoHerb

★ ʻO ka uhaki ʻana i ka ʻōlelo ma luna, e ʻimi ʻo GanoHerb i kāna mau kuleana pili kānāwai

★ Ua kākau ʻia ka kikokikona kumu o kēia ʻatikala ma ka ʻōlelo Pākē e Wu Tingyao a unuhi ʻia i ka ʻōlelo Pelekania e Alfred Liu.Inā loaʻa kekahi ʻokoʻa ma waena o ka unuhi (English) a me ka unuhi mua (Pake), e lanakila ka Pākē mua.Inā he nīnau ka poʻe heluhelu, e ʻoluʻolu e kelepona i ka mea kākau kumu, ʻo Ms. Wu Tingyao.

E hoʻomau i ka Moʻomeheu Ola Millennia
Hāʻawi i ka Ola no nā mea a pau